Aveanna Healthcare Holdings (AVAH) Cash & Equivalents (2021 - 2026)

Aveanna Healthcare Holdings has reported Cash & Equivalents for 6 years, with the latest figure at $193.3 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 129.29% year-over-year to $193.3 million; the trailing twelve-month figure through Jan 2026 stood at $193.3 million (up 129.29% YoY), and the FY2026 full-year result was $193.3 million, up 129.29% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $193.3 million, up from $145.9 million in the prior quarter.
• The five-year high for Cash & Equivalents was $193.3 million in Q1 2026, with the low at $17.4 million in Q2 2022.
• Historically, Cash & Equivalents has averaged $62.8 million across 5 years, with a median of $47.7 million in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 83.61% — and 2026, when it jumped 129.29%.
• Aveanna Healthcare Holdings' Cash & Equivalents stood at $19.2 million in 2022, then soared by 128.66% to $43.9 million in 2023, then soared by 91.82% to $84.3 million in 2024, then jumped by 73.06% to $145.9 million in 2025, then soared by 32.49% to $193.3 million in 2026.
• The last three Cash & Equivalents figures came in at $193.3 million (Q1 2026), $145.9 million (Q3 2025), and $100.7 million (Q2 2025), per Business Quant data.